Related Experiment Video
Updated: Aug 19, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
Published on: January 12, 2022
[TNFalpha inhibitors in the treatment of uveitis]
Abstract:
Tumor necrosis factor alpha (TNFalpha) is a pleiotropic cytokine that plays a pivotal role in chronic inflammatory diseases. Data from animal experiments indicate that TNFalpha is an important part of the pro-inflammatory processes in non-infectious uveitis. Neutralization of TNFalpha with TNF receptor fusion proteins or monoclonal antibodies, therefore, represents a promising strategy for the treatment of uveitis. In addition, the currently available TNFalpha inhibitors demonstrate a favourable profile of side effects compared to conventional immunosuppressive agents. Previous studies showed the immunological efficacy of TNFalpha inhibitors in the treatment of posterior uveitis. However, the available data on anterior uveitis are inconclusive with respect to the clinical efficacy of these agents.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Inhibitors of Viral Protein Synthesis
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Angle Closure Glaucoma: Treatment
